Low-Substituted Hydroxypropyl Cellulose

ExcipientUNII 2165RE0K14

5 organisations hold 5 active FDA Type IV Drug Master Files for Low-Substituted Hydroxypropyl Cellulose.

Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity). Methodology

Active Type IV DMFs (5)

HolderDMFFiled asSubmitted
G.C. CHEMIE PHARMIE LTD37972LOW- SUBSTITUTED HYDROXYPROPYL CELLULOSEApr 2023
SHANDONG LIAOCHENG E HUA PHARMACEUTICAL CO LTD36210LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSESept 2021
Huzhou Zhanwang Pharmaceutical Co.,ltd.
China
35898LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSEMay 2021
ANHUI SUNHERE PHARMACEUTICAL EXCIPIENTS CO LTD35157LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSENov 2020
SHIN-ETSU CHEMICAL CO LTD3127L-HPC (LOW-SUBSTITUTED HYDROXYPYL CELLULOSE)Feb 1978

“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.

What these records establish

  • A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
  • Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
  • The holder is the organisation that filed. It is usually, but not always, the manufacturer.
  • Many excipients are supplied without any DMF, so this list is not every supplier of Low-Substituted Hydroxypropyl Cellulose.

How to qualify an excipient supplier

For suppliers

Do you supply Low-Substituted Hydroxypropyl Cellulose?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.